← All trials
NCT00442455
Phase 3Interventional
Includes trials conducted after preliminary evidence suggesting effectiveness of the drug has been obtained, and are intended to gather additional information to evaluate the overall benefit-risk relationship of the drug.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 1, 2006
- Primary completion
- Aug 1, 2015
- Completion date
- Aug 1, 2015
- First posted
- —
- Last posted
- —
- Enrollment
- 53
- Arms / groups
- 1 / —
- Source
- AACT · pre-existing
Sponsors
- Grupo de Investigación Clínica en Oncología RadioterapiaLead sponsor
- Hospital Regional Universitario Carlos HayaOverall official - principal investigator
- Grupo de Investigación Clínica en Oncología RadioterapiaReponsible party - principal investigator
- Clinica Universidad de NavarraOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.